As of Feb 11
| +0.15 / +14.85%|
The 4 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +632.76% increase from the last price of 1.16.
The current consensus among 4 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.